Acurx Pharmaceuticals LLC
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,246 | -2,149 | -2,781 | -2,821 |
EBIT | -2,269 | -2,149 | -2,781 | -5,644 |
Net Income | -2,246 | -2,149 | -2,781 | -2,821 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,670 | -2,051 | -2,250 | -2,189 |
Cash | 6,064 | 4,643 | 3,706 | 5,762 |
Basic Shares | 1,190 | 1,001 | 851 | 818 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -14,103 | -14,577 | -12,092 | -12,814 |
EBIT | -14,103 | -29,156 | -24,186 | -12,880 |
Net Income | -14,103 | -14,577 | -12,092 | -12,681 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,383 | -9,800 | -7,542 | -5,013 |
Cash | 3,706 | 7,474 | 9,111 | 12,958 |
Basic Shares | 851 | 633 | 540 | 510 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.89 |
2025-03-31 | -$0.11 |
2024-12-31 | -$0.16 |
